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The mitochondrial Uncoupling Protein 2 UCP2 is a member of
the mitochondrial carrier family and belongs to the UCP subfamily.
It is widely expressed in tissues. In immune cells, UCP2 has a
regulatory function through its effect on the production of reactive
oxygen species and MAPK signalling. Ucp2−/− mice are resistant to
infection by parasites and intracellular bacteria but are more
sensitive to chronic inﬂammation and experimental neurodegen-
eration. We found that autoimmune diabetes was strongly
accelerated in Ucp2−/− mice compared to Ucp2+/+ mice with
increased intra-islet lymphocytic inﬁltration. These data highlight
UCP2 as a new player in autoimmune diabetes. In addition, in
agreement with the known inhibitory role of UCP2 on insulin
secretion, loss of function of UCP2 contributes to congenital
hyperinsulinism in patients. The question of whether UCP2 fully
uncouples respiration from ATP synthesis is still debated. Ucp2−/−
cells display enhanced proliferation associated with a metabolic
switch from fatty acid oxidation to glucose metabolism. This
metabolic switch requires the unrestricted availability of glucose,
and Ucp2−/− cells more readily activate autophagy than wild-type
cells when deprived of glucose. Altogether, these results suggest
that UCP2 promotes mitochondrial fatty acid oxidation while
limiting mitochondrial catabolism of pyruvate. UCP2 expression is
also required for efﬁcient oxidation of glutamine in macrophages.
This role of UCP2 in glutamine metabolism appears independent
from its uncoupling activity.
doi:10.1016/j.bbabio.2008.05.028
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At physiological concentrations nitric oxide (NO) inhibits
mitochondrial cytochrome c oxidase in competition with oxygen.
Using a technique based on visible light spectroscopy we have
demonstrated that endogenous NO enhances the reduction of the
electron transport chain, thus enabling cells to maintain their VO2 at
low [O2]. This favours the release of superoxide anion, which
initiates the transcriptional activation of NF-κB as an early stress
signalling response. We have recently used this technique to
demonstrate that NO is inactivated by cytochrome c oxidase in its
oxidised state and that cessation of such inactivation at low [O2]
may account for hypoxic vasodilatation. Many cells respond to a
decrease in oxygen availability via stabilisation of hypoxia-inducible
factor-1α (HIF-1α), whose accumulation is normally prevented by
the action of prolyl hydroxylases. We have found that inhibition of
mitochondrial respiration by low concentrations of NO leads to
inhibition of HIF-1α stabilisation. This prevents the cell from
registering a state of hypoxia at low [O2], which would otherwise
result in upregulation of defensive genes associated with, for
example, glycolysis and angiogenesis. Furthermore, upon inhibition
of mitochondrial respiration in hypoxia, oxygen is redistributed
toward non-respiratory oxygen-dependent targets.
Our results demonstrate that NO acts not only as a physiological
regulator of cell respiration but also as a signalling agent in the
mitochondria and a controller of the distribution of available oxygen.
Such mechanisms may also be involved in the initiation of
pathophysiology.
doi:10.1016/j.bbabio.2008.05.029
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A concept is developed considering aging as an evolution-
facilitating program which is unnecessary and counterproductive
for human and, therefore, should be arrested. To do this, an
attempt is undertaken to inactive mitochondria-produced reactive
oxygen species (ROS) which seem to mediate execution of the
aging program. We synthesized mitochondria-targeted, recharge-
able, hydrophobic antioxidant composed of plastoquinone and
cation of decyltriphenylphosphonium (SkQ1). It is shown that
very low (nmol/kg/day) amounts of SkQ1 increase the lifespan of a
fungus (Podospora anserine), invertebrates (Ceriodaphnia afﬁnis and
Drosophila melanogaster) and a mammal (mouse). Even more
important, in mice SkQ1 abrogates development of such typical
traits of senescence as osteoporosis (kyphosis), decrease in
resistance to infections, depression, alopecia, loss of whiskers,
gray hairs, disappearance of regular oestrous cycles, etc. In rats,
pretreatment with SkQ1 or its homolog, SkQR1, has favourable
effect in the cases of experimental heart arrhythmia, heart and
kidney infarction or stroke. In rats, rabbits, cats, dogs and horses,
drops of 250 nM SkQ1 prevent development of certain types of
cataract, retinopathies and uveitis and in some cases return vision
to animals that became blind due to these pathologies. These data
are consistent with the assumption that SkQ1 interferes with
execution of aging program and is promising in treating some age-
related diseases.
Sponsored by O.V. Deripaska; for review, see Skulachev, V.P.
Biochemistry (Moscow), 2007, 72, 1385-1396; http://protein.bio.msu.
ru/biokhimiya/contents/v72/pdf/bcm_1385.pdf.
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Cytochrome c oxidases, members of the superfamily of heme-
copper containing terminal oxidases, catalyse the reduction of
molecular oxygen to water. Catalytic cycles consist of the oxidized
O-state, the one and two electron reduced E and R-states. The R-
state reacts with oxygen to form the P-state, input of the third
electron leads to the F-state, which is converted to the O-state
again after receiving the fourth electron. The P- (“Peroxy”) and F-
(Ferryl) states are oxoferryl states. Presently the binuclear heme
Fea3–CuB active site is believed to contain either a hydroxyl group
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at CuB in the O-state, or an additional hydroxyl group at Fea3.
However, the electron densities of all high resolution structures are
compatible best with a peroxo-bridge between Fea3 and CuB. In
addition, we ﬁnd that the F-state generated in the traditional way
by an excess of H2O2, can be converted into a P-state simply by
addition of catalase. Finally we have discovered conditions under
which the O-state spontaneously converts into a P-state with
concomitant formation of a tyrosine radical. All these results can be
understood best if the catalytic cycle starts with an O-state
containing a bridging peroxide dianion and the F-state contains a
superoxide bound to CuB.
doi:10.1016/j.bbabio.2008.05.031
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The cytochrome c oxidases (CcO), which are responsible for most
of the O2 consumption in biology, are also redox-linked proton
pumps that effectively convert the free energy of O2 reduction to an
electrochemical proton gradient across mitochondrial and bacterial
membranes. Recently, time-resolved measurements have elucidated
the sequence of events in proton translocation, and shed light on
the underlying molecular mechanisms. One crucial property of the
proton pump mechanism has received less attention, viz. how
proton leaks are avoided. Here, we will analyse this topic and
demonstrate how the key proton-carrying residue Glu-242 (num-
bering according to the sequence of subunit I of bovine heart CcO)
functions as a valve that has the effect of minimising back-leakage
of the pumped proton.
doi:10.1016/j.bbabio.2008.05.032
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All known proton pumping respiratory oxidases are members of
the heme-copper superfamily. This superfamily contains not only
the oxygen reductases (respiratory oxidases) but also prokaryotic
NO reductases that are used for denitriﬁcation and detoxiﬁcation.
Our work has focused on the largest group of respiratory oxidases,
the A-family, with the aim being to understand how the chemistry
of reducing oxygen to water is coupled to driving a unidirectional
proton pump. Most studies have used the aa3-type oxidase from R.
sphaeroides. Mutations in one of the two proton input channels, the
D channel, can decouple the proton pump from the redox
chemistry. The properties of these mutants will be discussed.
Recent studies have included respiratory oxidases that are not
members of the major (canonical) family of heme-copper oxidases,
but are in the B- and C-families. This includes work on the ba3-
type oxidase from Thermus thermophilus, in a collaboration with
the group of Dr. James Fee (Scripps Institute). Results will be
discussed.
doi:10.1016/j.bbabio.2008.05.033
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In cellular respiration, the mobile electron carrier cytochrome c
shuttles electrons from cytochrome bc1 complex to cytochrome c
oxidase. The X-ray structure of the complex between cytochrome c
and cytochrome bc1 complex at 2.97-Å resolution gave the ﬁrst
structural insight for such a complex from the respiratory chain.
The structure revealed the general features of the interface, which
is well suited for transient interaction and fast turnover. Remark-
ably, cytochrome c binds to only one recognition site of the
homodimeric complex. We now determined the structure of the
electron transfer complex in the reduced state at 1.9-Å resolution.
The high resolution allows an accurate description of the interface,
especially of electrostatic and water-mediated interactions. The
dimer structure is asymmetric. Monovalent cytochrome c binding
is correlated with conformational changes of the Rieske head
domain and subunit QCR6p and with a higher number of
interfacial water molecules bound to cytochrome c1. Comparison
with a second structure obtained for isoform-2 cytochrome c
bound to the cytochrome bc1 complex led to the deﬁnition of a
minimal interface, the so-called core interface, which is present in
all of these structures. The importance of single core interface
residues for formation of the reactive complex in solution was
probed by site-directed mutagenesis and characterization of the
variants.
doi:10.1016/j.bbabio.2008.05.034
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Ullrich Congenital Muscular Dystrophy (UCMD) and Bethlem
Myopathy (BM) are muscle diseases due to mutations in the genes
encoding the extracellular matrix protein collagen VI. Generation of a
dystrophic mouse model where collagen VI synthesis was prevented
by genetic ablation of the Col6a1 gene allowed an investigation of
pathogenesis, which revealed the existence of a Ca2+-mediated
dysfunction of mitochondria and the sarcoplasmic reticulum. A key
event appears to be inappropriate opening of the mitochondrial
permeability transition pore, an inner membrane high-conductance
channel. Consistently, the Col6a1−/− myopathic mice could be cured
with cyclosporin A through inhibition of cyclophilin D, a matrix
protein that sensitizes the pore to opening. Studies of myoblasts from
UCMD and BM patients demonstrated the existence of a latent
mitochondrial dysfunction irrespective of the genetic lesion respon-
sible for the lack or the alteration of collagen VI. These studies suggest
that PTP opening may represent the ﬁnal common pathway for
skeletal muscle ﬁber death; and provided a rationale for a pilot clinical
trial with cyclosporin A in patients affected by UCMD and BM. Prior to
treatment, all patients displayed mitochondrial dysfunction and
increased frequency of apoptosis, as determined in muscle biopsies.
Both these pathological signs were largely normalized after 1 month
of oral cyclosporin A administration, which also increased muscle
regeneration. These results indicate that mitochondrial dysfunction
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